Biotricity Inc (BTCY)

Name: Biotricity Inc Financial Statements
Creator: Quarter Results

Healthcare | Medical Devices

Latest reporting period: 2025-12-31

Latest Quarter

2025-12-31

Revenue

$4.0M

Net Income

-$717K

Operating Margin

11.1%

Free Cash Flow

-$2.4M

Debt / Assets

632.1%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Biotricity Inc (BTCY).
Income Statement (Quarterly)	2025-12-31	2025-09-30	2025-06-30	2024-12-31
Revenue	3,987,819	3,885,795	3,873,993	3,619,108
Cost of Revenue	736,343	704,297	757,193	855,140
Gross Profit	3,251,476	3,181,498	3,116,800	2,763,968
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	2,186,994	2,304,881	2,138,692	2,381,734
Operating Expenses	2,810,561	2,907,679	2,834,855	2,932,950
Operating Income	440,915	273,819	281,945	-168,982
Interest Expense	995,809	860,419	1,003,826	1,140,666
Income Before Tax	-717,067	-690,913	-671,977	-1,229,154
Income Tax Expense	0	0	0	89,392
Net Income	-717,067	-690,913	-671,977	-1,229,154
Per Share
EPS	-0.04	-0.03	-0.03	-0.05
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Biotricity Inc (BTCY).
Income Statement (Annual)	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31
Revenue	13,790,294	12,063,345	9,639,057	7,650,269	3,384,767
Cost of Revenue	3,225,803	3,707,064	4,197,024	3,080,116	1,871,125
Gross Profit	10,564,491	8,356,281	5,442,033	4,570,153	1,513,642
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	10,857,797	14,612,724	17,621,865	18,562,369	12,806,306
Operating Expenses	13,013,457	17,184,550	20,851,744	21,306,956	14,865,436
Operating Income	-2,448,966	-8,828,269	-15,591,652	-17,877,325	-13,351,794
Interest Expense	5,201,854	5,191,723	2,582,618	10,569,593	2,481,155
Income Before Tax	-8,421,179	-14,094,283	-18,658,143	-29,130,477	-15,491,176
Income Tax Expense	0	0	2,400,677	9,429,071	0
Net Income	-8,421,179	-14,094,283	-18,658,143	-29,130,477	-15,491,176
Per Share
EPS	-0.55	-1.66	-2.15	-3.85	-0.44
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Biotricity Inc (BTCY).
Balance Sheet (Quarterly)	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Assets
Cash and Cash Equivalents	365,145	786,060	570,460	12,066,929
Short Term Investments	0	0	588,599	0
Net Receivables	2,718,762	1,805,111	1,224,137	2,412,958
Inventory	1,555,385	1,879,402	2,337,006	842,924
Total Current Assets	4,639,292	4,470,573	4,720,202	15,322,811
Property Plant Equipment	821,652	1,237,145	1,608,998	1,270,159
Goodwill and Intangibles	0	0	0	0
Total Assets	5,640,954	5,942,625	6,510,544	16,677,970
Liabilities
Account Payables	4,602,309	5,221,992	3,435,123	1,159,477
Short Term Debt	12,550,024	12,093,842	5,110,076	1,750,320
Total Current Liabilities	20,636,148	22,698,826	11,160,768	4,866,814
Long Term Debt	13,540,189	11,784,948	14,436,096	13,603,490
Total Liabilities	35,655,054	35,919,442	26,355,929	18,822,706
Shareholders Equity
Retained Earnings	-139,441,785	-127,499,785	-112,570,825	-93,037,142
Total Shareholders Equity	-30,014,100	-29,976,817	-19,845,385	-2,144,736

Balance sheet annual history for Biotricity Inc (BTCY).
Balance Sheet (Annual)	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31
Assets
Cash and Cash Equivalents	365,145	786,060	570,460	12,066,929	2,201,562
Short Term Investments	0	0	588,599	0	0
Net Receivables	2,718,762	1,805,111	1,224,137	2,412,958	1,847,500
Inventory	1,555,385	1,879,402	2,337,006	842,924	272,493
Total Current Assets	4,639,292	4,470,573	4,720,202	15,322,811	4,321,555
Property Plant Equipment	821,652	1,237,145	1,608,998	1,270,159	66,120
Goodwill and Intangibles	0	0	0	0	0
Total Assets	5,640,954	5,942,625	6,510,544	16,677,970	4,438,033
Liabilities
Account Payables	4,602,309	5,221,992	3,435,123	1,159,477	1,041,385
Short Term Debt	12,550,024	12,093,842	5,110,076	1,750,320	4,336,275
Total Current Liabilities	20,636,148	22,698,826	11,160,768	4,866,814	10,490,255
Long Term Debt	13,540,189	11,784,948	14,436,096	13,603,490	370,900
Total Liabilities	35,655,054	35,919,442	26,355,929	18,822,706	11,271,197
Shareholders Equity
Retained Earnings	-139,441,785	-127,499,785	-112,570,825	-93,037,142	-62,817,688
Total Shareholders Equity	-30,014,100	-29,976,817	-19,845,385	-2,144,736	-6,833,164

Cash flow quarterly history for Biotricity Inc (BTCY).
Cash Flow Statement (Quarterly)	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Operating Activities
Net Income	-8,421,179	-14,094,283	-18,658,143	-29,130,477
Depreciation & Amortization	5,953	2,172,920	5,953	2,308
Stock Based Compensation	1,461,698	1,025,930	647,631	913,613
Change in Working Capital	962,229	3,682,697	2,308,764	-117,583
Operating Cash Flow	-2,380,177	-6,693,912	-13,547,935	-15,163,384
Investing Activities
Capital Expenditure	-3	0	0	-29,767
Investments	0	0	0	-29,767
Investing Cash Flow	0	0	0	-29,767
Financing Activities
Debt Repayment	101,484	3,815,416	-3,831,440	-1,660,220
Common Stock Issued/Repurchased	125,227	119,285	-883,056	14,565,805
Dividends Paid	-29,984	-18,016	-946,780	-966,110
Financing Cash Flow	1,929,259	6,741,685	2,001,603	25,168,230
Summary
Free Cash Flow	-2,380,177	-6,693,912	-13,547,935	-15,193,151
Net Change in Cash	-420,915	215,600	-11,496,469	9,865,367

Cash flow annual history for Biotricity Inc (BTCY).
Cash Flow Statement (Annual)	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31
Operating Activities
Net Income	-8,421,179	-14,094,283	-18,658,143	-29,130,477	-15,491,176
Depreciation & Amortization	5,953	2,172,920	5,953	2,308	0
Stock Based Compensation	1,461,698	1,025,930	647,631	913,613	790,535
Change in Working Capital	962,229	3,682,697	2,308,764	-117,583	-627,902
Operating Cash Flow	-2,380,177	-6,693,912	-13,547,935	-15,163,384	-11,080,831
Investing Activities
Capital Expenditure	-3	0	0	-29,767	0
Investments	0	0	0	-29,767	0
Investing Cash Flow	0	0	0	-29,767	0
Financing Activities
Debt Repayment	101,484	3,815,416	-3,831,440	-1,660,220	-408,082
Common Stock Issued/Repurchased	125,227	119,285	-883,056	14,565,805	0
Dividends Paid	-29,984	-18,016	-946,780	-966,110	-602,969
Financing Cash Flow	1,929,259	6,741,685	2,001,603	25,168,230	12,203,480
Summary
Free Cash Flow	-2,380,177	-6,693,912	-13,547,935	-15,193,151	-11,080,831
Net Change in Cash	-420,915	215,600	-11,496,469	9,865,367	1,251,714